Health Care Industry
Industry: Email Alert RSS FeedPurepac receives approval for Spironolactone tablets
Drug Store News, Sept 27, 1999
Purepac Pharmaceutical Co., a subsidiary of FH Faulding & Co. Limited, has received FDA approval for its ANDA for Spironolactone tablets USP, 50 mg and 100 mg, the generic equivalent of Aldactone brand tablets marketed by Searle. Spironolactone is a pharmacological antagonist of the hormone aldosterone and acts as a diuretic and anti-hypertensive drug by this mechanism.
Most RecentHealth Care Articles
The product is indicated in the management of primary hyperaldosteronism and edematous conditions for patients with a number of conditions, including congestive heart failure.
COPYRIGHT 1999 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
Most Popular Health Publications
Content provided in partnership with
